Immunocore Holdings plc (FRA:6YG)

Germany · Delayed Price · Currency is EUR

24.00

-1.00 (-4.00%)

Last updated: Jun 3, 2026, 7:55 PM CET

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Immunotherapies	400.02M	310.20M	249.43M	174.36M	36.48M
Immunotherapies Growth	28.95%	24.37%	43.05%	377.91%	-11.26%
Total	400.02M	310.20M	249.43M	174.36M	36.48M
Total Growth	28.95%	24.37%	43.05%	377.91%	-11.26%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	257.00M	226.69M	169.79M	96.89M	-
United States Growth	13.37%	33.51%	75.24%	-	-
Europe	131.42M	73.22M	67.63M	42.75M	4.08M
Europe Growth	79.48%	8.27%	58.21%	948.19%	-
International	11.60M	10.08M	1.32M	1.05M	-
International Growth	15.06%	665.81%	25.45%	-	-
Total	400.02M	309.99M	238.74M	140.69M	4.08M
Total Growth	29.04%	29.85%	69.69%	3349.90%	-

Source: S&P Global Market Intelligence.